Adderall (Amphetamine): Dependence, Withdrawal, and Recovery Support

Adderall is the best-known prescription stimulant in the United States, and most people who take it have a real diagnosis and never run into trouble. That is worth saying first, because the shame around this drug runs both ways: people with ADHD feel judged for needing it, and people who have lost control of it feel they cannot admit it. In May 2023 the FDA ordered every prescription stimulant, Adderall included, to carry an updated boxed warning on abuse, misuse, and addiction (FDA, 2023), and in 2024 an estimated 3.9 million Americans misused a prescription stimulant (SAMHSA NSDUH, 2024). It is hard to stop because the focus and energy that made it useful are exactly what disappear in withdrawal, and the crash can be deep. This page covers dependence, withdrawal, treatment when there is no medication to prescribe, and how weekly support at home fits.

What Adderall is and how it works

Adderall is a mix of four amphetamine salts, sold as immediate-release tablets, Adderall XR extended-release capsules, and generics labeled "amphetamine mixed salts." The label lists two approved uses: "the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy" (Adderall prescribing information, section 1). It is a Schedule II controlled substance, the same category as oxycodone and methamphetamine (DEA). On campuses it goes by "addy," "study buddies," or "smart pills," and amphetamines in general by "beans" (DEA, 2018); the older slang is "speed" and "uppers" (DEA).

Amphetamine raises the dopamine and norepinephrine working in the brain. At a prescribed dose in someone with ADHD, that steadies attention. At higher doses, or crushed and snorted, it produces euphoria, and with chronic heavy use "a psychosis that resembles schizophrenia: paranoia, hallucinations, violent and erratic behavior" (DEA). The drug also lasts a while. The label reports a mean elimination half-life of "9.77 to 11 hours" for d-amphetamine and "11.5 to 13.8 hours" for l-amphetamine (section 12.3), which is why a late dose ruins sleep and the crash arrives the next day rather than the same evening.

The supply problem changed who takes what. The FDA posted a shortage of immediate-release Adderall on October 12, 2022 (FDA, 2022), and by August 2023 the DEA and FDA were writing jointly that manufacturers had left "approximately 1 billion more doses that they could have produced but did not make or ship" (DEA and FDA, 2023). Among adults with ADHD taking a stimulant in late 2023, 71.5 percent had trouble getting a prescription filled because the medication was not available (CDC MMWR, 2024). People switched doses, borrowed from friends, or bought online, which is where the counterfeit problem starts. The DEA's public safety alert names "amphetamines (Adderall)" among the pills criminal networks copy and warns that "methamphetamine is increasingly being pressed into counterfeit pills" (DEA, 2021). DEA lab testing finds that 5 out of every 10 counterfeit pills with fentanyl hold a potentially lethal dose (DEA, One Pill Can Kill). A pill from a friend of a friend may be Adderall, may be meth, and may be neither.

Dependence, misuse, and addiction are not the same thing

The label defines all three, and it matters because families use the words as if they were one thing. Physical dependence "is a state that develops as a result of physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dose reduction" (section 9.3). Someone who has taken 20 mg every morning for eight years, exactly as written, will feel flat and exhausted if the pharmacy runs dry. That is dependence. It says nothing about character.

Misuse, in the label's words, is "intentional use, for therapeutic purposes, of a drug by an individual in a way other than prescribed by a health care provider or for whom it was not prescribed," while abuse is "intentional non-therapeutic use of a drug, even once, to achieve a desired psychological or physiological effect" (section 9.2). A roommate's pill before an exam is misuse; snorting three to stay up all night is abuse. A stimulant use disorder, what most people mean by addiction, is the label's "cluster of behavioral, cognitive, and physiological phenomena that may include a strong desire to take the drug, difficulties in controlling drug use," and continued use despite harm.

The numbers keep this in proportion. About 15.5 million U.S. adults have an ADHD diagnosis, and roughly a third took a stimulant in the past year (CDC MMWR, 2024). The FDA found that misuse of a person's own prescription "accounted for approximately 10 percent to 20 percent" of past-year misusers; the usual source was "friends or family members, with estimates generally ranging from 56 percent to 80 percent" (FDA, 2023). Misuse concentrates in young adults: 2.8 percent of 18 to 25 year olds, about 973,000 people, misused a prescription stimulant in 2024 (SAMHSA NSDUH, 2024). Most people with a prescription are fine. Some are not, and a diagnosis does not protect you from losing control of the pill that treats it.

Signs Adderall has become a problem

What members and families describe to us looks like this. The dose has crept up, first on deadline days, then most days, and a 30-day supply is gone in three weeks. Pills are being crushed and snorted, which the label flags among the "unapproved methods of administration" that raise overdose risk (boxed warning). Sleep has collapsed to a few hours, weight has dropped, and the person is irritable and jumpy. There is a second source: a friend's bottle, a second prescriber, a dealer on a messaging app. The label's picture of abuse includes "restlessness; insomnia; decreased appetite; loss of coordination; tremors," and adds that "Anxiety, psychosis, hostility, aggression, and suicidal or homicidal ideation have also been observed" (section 9.2). Paranoia is the sign families find hardest to name out loud: checking the locks, hearing the neighbors talk about them. If that is happening, it needs a clinician today.

Is stopping Adderall dangerous?

Rarely, in the way alcohol or benzodiazepine withdrawal can be. SAMHSA's protocol states that "No consistent physiologic disruptions requiring gradual withdrawal have been observed" (SAMHSA TIP 33, Chapter 3). The danger sits somewhere else, and the same document is direct about it: "The greatest risk during stimulant withdrawal is of doing harm to self. Because withdrawal-related dysphoria and depression can be particularly severe in people using stimulants, risk of suicide is intensified and sensitive management is essential." The label's withdrawal list, "dysphoric mood; depression; fatigue; vivid, unpleasant dreams; insomnia or hypersomnia; increased appetite; and psychomotor retardation or agitation" (section 9.3), reads mild on paper. Lived, it is waking after fourteen hours still exhausted, with no interest in anything and a voice saying it will always be like this. If that voice turns toward not wanting to be here, call or text 988; the Lifeline is "available 24/7/365" and free (988 Lifeline). Families should know this window exists and stay close through it.

Two other cautions. If Adderall was prescribed for ADHD, stopping abruptly means the ADHD comes back on top of the crash; whether to taper, stop, or switch to a non-stimulant is a prescriber's call. And if the pills were bought, get a medical evaluation, because nobody knows what was in them.

Adderall withdrawal timeline

Timing varies with dose, duration, binge patterns, and how little you were sleeping. SAMHSA describes the amphetamine-type pattern as "a drastic drop in mood and energy levels" arriving "over the course of 1 to 14 days after last use" (SAMHSA TIP 33, Chapter 2). This is the general shape.

First 24 to 48 hours

With half-lives around 10 to 13 hours, the drug is mostly gone within two days. People notice hunger first, then a heaviness that makes standing up feel like work. Someone who has been sleeping four hours a night may sleep twelve.

Days 2 to 7

This is the crash proper: depressed mood, no pleasure in anything, vivid dreams, and either agitation or slowness. SAMHSA describes sleep after heavy use lasting "more or less uninterrupted for several days," after which "the individual may experience mild to severe depression" (TIP 33, Chapter 2). Suicide risk is highest here. It is also when "one to get through the week" happens, which is why a plan for these days matters more than resolve.

Weeks 2 to 4

Energy and sleep start to normalize. Mood lags. For amphetamine-type stimulants SAMHSA notes that symptoms "may persist for 2 to 4 weeks" (TIP 33, Chapter 3). Cravings attach to cues: a deadline, a long drive, the first hour of the workday that used to come with a pill.

Beyond a month

Some people feel flat for months, and it is hard to tell what is lingering withdrawal, what is untreated ADHD, and what is a depression the stimulant had been covering. This stretch is where support earns its keep.

How treatment works

Nothing does for stimulants what buprenorphine does for opioids. SAMHSA states it plainly: "There are no FDA-approved medications for managing stimulant use disorders" (SAMHSA TIP 33, Executive Summary). What works is behavioral. The 2024 ASAM and American Academy of Addiction Psychiatry guideline says contingency management "has demonstrated the best effectiveness in the treatment of stimulant use disorders (StUDs) compared to any other intervention studied and represents the current standard of care" (ASAM/AAAP, 2024). Contingency management means tangible rewards tied to verified negative tests, which is why testing sits at the center of stimulant treatment. The guideline also gives cognitive behavioral therapy a strong recommendation, and for amphetamine-type use disorder it says clinicians "can consider prescribing bupropion in combination with naltrexone," with mirtazapine or topiramate as lower-certainty options (Recommendations 12 to 14).

The harder question for many members is what happens to the ADHD, because someone who developed a use disorder on a legitimate prescription usually still has the diagnosis. That belongs with a prescriber who knows the whole history. Options range from a non-stimulant to a supervised stimulant with someone else holding the bottle, and the label tells prescribers to "reassess each patient's risk of abuse, misuse, and addiction" throughout treatment (Adderall XR prescribing information, section 5.1), which is the arrangement recovery support makes workable.

Adderall with alcohol, other stimulants, or MAOIs

Alcohol is the combination we hear about most. A stimulant keeps you awake and feeling capable while your blood alcohol climbs, so people drink past where they would have stopped. The CDC warns that mixing stimulants and depressants gives results that are "unpredictable, often modifying or even masking the effects of one or both drugs. This may trick you into thinking that the drugs are not affecting you, making it easier to overdose" (CDC, 2024). The two travel together: "college students who misuse prescription stimulants are over six times more likely to report heavy drinking than those who do not" (SAMHSA, 2021).

The heart pays. The label warns that "Sudden death has been reported in patients with structural cardiac abnormalities or other serious cardiac disease" at ordinary ADHD doses, and that stimulants raise blood pressure and heart rate even when taken correctly (Adderall XR prescribing information, sections 5.2 and 5.3). Stacking Adderall on cocaine or methamphetamine multiplies that load. The overdose section describes the extreme: "Vasospasm, myocardial infarction, or aortic dissection may precipitate sudden cardiac death," along with agitation, hallucinations, seizures, and "Life-threatening hyperthermia" (section 10).

The one absolute contraindication is an MAOI antidepressant: no Adderall for patients on an MAOI "or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis" (section 4). If you take any antidepressant and stimulants nobody prescribed alongside it, tell someone.

Drug testing for Adderall

Amphetamine is on every standard panel. Under the federal oral fluid guidelines the initial cutoff for amphetamines is 50 ng/mL, with confirmation at 25 ng/mL for each analyte (Federal Register, 2019). A prescribed dose will test positive, which is expected; what matters is whether the result matches the plan. Immunoassays can also cross-react, since "Some over-the-counter (OTC) decongestants (e.g., pseudoephedrine) register a positive drug test result for amphetamine" (SAMHSA TAP 32, 2012), so a screen that matters gets lab confirmation.

Detection windows are shorter than people expect. The FDA's guidance on home urine tests gives amphetamines roughly 2 to 3 days after last use (FDA). Saliva is shorter still: SAMHSA's general figure is that oral fluid detects use during the previous 24 to 48 hours (TAP 32). We have not found a well-controlled study of amphetamine in saliva after heavy repeated use; given half-lives of 10 to 13 hours, a day or two is the honest range, and nothing stretches it to a week.

Short windows are why our screening is random. Members use saliva-based testing assigned at random through the week, so no day is safe to skip. You do not choose whether you test; you choose who sees the results, usually the prescriber and, if the member wants, a parent or partner. We explain the details in our guide to how sobriety monitoring works.

How recovery from Adderall works with Accountable

We are not a detox and we do not prescribe. Tapering, non-stimulant alternatives, or an antidepressant during the crash belong to your doctor. What we provide is the behavioral part the guidelines keep pointing to, at home, for as long as you need it.

1. Get the full picture

In the first sessions your coach maps what is actually happening: how much and how often, whether the pills are prescribed or bought, whether anything has been snorted, how sleep and eating have been, whether paranoia has shown up, and what else is in the mix, alcohol above all. If ADHD is underneath, we help you find a prescriber who can see the whole history, and with your permission we coordinate so everyone works from one plan.

2. Build a plan that fits your life

Stimulant recovery lives in the calendar. Your coach helps you plan the crash week so it does not land on finals or a product launch, then plan the cues: the deadline, the road trip, the 6 a.m. alarm. Sleep is the first job. Daily peer group meetings give you people who know what day nine feels like, and the weekly family Zoom group gives the people around you their own place to get support.

3. Weekly check-ins through the long stretch

Weeks three through twelve are where stimulant recovery quietly fails: the crash has passed, the motivation has not come back, and one pill looks like the reasonable fix. Your coach shows up every week, and the random saliva screening turns "I think she's doing okay" into a shared record that you control and that a prescriber can rely on if a supervised ADHD medication is ever back on the table. When a return to use happens, we treat it as information: the plan changes and the support goes up. Every coach at Accountable has their own recovery behind them, and many have been through stimulants.

Accountable is covered by a growing list of commercial health plans, with more added each month, and private-pay plans start at $375 per month. You can check your coverage in a few minutes or call the care team at (646) 450-7641. Families are welcome to make the first call; see our page for families.

Common questions

How long does Adderall stay in your system?

The half-lives are roughly 10 hours for d-amphetamine and 13 hours for l-amphetamine (Adderall XR prescribing information, section 12.3), so most of a dose is gone within two days. Urine tests typically detect amphetamines for about 2 to 3 days after last use (FDA), saliva for roughly a day or two. Heavy daily use and urine acidity shift these a little.

How long does Adderall withdrawal last?

The crash usually hits within a day or two and is worst in the first week. SAMHSA describes amphetamine-type withdrawal symptoms persisting "for 2 to 4 weeks" (SAMHSA TIP 33), with cravings and low motivation sometimes lasting longer. If low mood is still heavy after a month, talk to a clinician; untreated ADHD or depression may be part of it.

Can you get addicted to Adderall if you have ADHD and take it as prescribed?

Dependence, meaning your body adapts and you feel withdrawal if you stop, is expected with steady use and is not a disorder (prescribing information, section 9.3). A use disorder is less common but possible, which is why the boxed warning tells prescribers to keep reassessing risk. Most misuse involves pills from someone else, not a person's own prescription (FDA, 2023).

Is there a medication to treat Adderall addiction?

No FDA-approved one. SAMHSA states that "There are no FDA-approved medications for managing stimulant use disorders" (SAMHSA TIP 33). Contingency management and cognitive behavioral therapy have the strongest evidence, and some prescribers use bupropion with naltrexone off-label (ASAM/AAAP, 2024).

What does an Adderall overdose look like, and what should I do?

Chest pain, a racing or irregular pulse, very high body temperature, seizures, severe agitation, or hallucinations; the label lists these among the effects of overdose (prescribing information, section 10). Call 911. If the pills were bought, tell the responders, because counterfeit "Adderall" has contained methamphetamine and fentanyl (DEA), and give naloxone if you have it. In 2023 nearly 35,000 overdose deaths involved psychostimulants, most of them methamphetamine (CDC, 2025).

Sources

• U.S. Food and Drug Administration. Adderall (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate) tablets, CII, prescribing information, revised October 2023.

• U.S. Food and Drug Administration. Adderall XR (mixed salts of a single-entity amphetamine product) extended-release capsules, prescribing information, revised October 2023.

• U.S. Food and Drug Administration. FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions. Drug Safety Communication, May 11, 2023.

• U.S. Food and Drug Administration. FDA Announces Shortage of Adderall. October 12, 2022.

• Drug Enforcement Administration and U.S. Food and Drug Administration. DEA and FDA Issue Joint Letter to the Public. August 1, 2023.

• Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults, National Center for Health Statistics Rapid Surveys System, United States, October to November 2023. MMWR Morbidity and Mortality Weekly Report, October 10, 2024.

• Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. 2025.

• Drug Enforcement Administration. Public Safety Alert: Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth. September 27, 2021.

• Drug Enforcement Administration. One Pill Can Kill, Get Smart About Drugs.

• Drug Enforcement Administration. Amphetamines drug fact sheet.

• Drug Enforcement Administration. Drug Scheduling.

• Drug Enforcement Administration, Houston Division. Slang Terms and Code Words: A Reference for Law Enforcement Personnel. DEA-HOU-DIR-022-18, July 2018.

• Substance Abuse and Mental Health Services Administration. TIP 33: Treatment for Stimulant Use Disorders, Executive Summary. Updated 2021, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. TIP 33: Treatment for Stimulant Use Disorders, Chapter 2: How Stimulants Affect the Brain and Behavior. Updated 2021, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. TIP 33: Treatment for Stimulant Use Disorders, Chapter 3: Medical Aspects of Stimulant Use Disorders. Updated 2021, NCBI Bookshelf.

• Batki S, Ciccarone D, Hadland SE, et al. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. Journal of Addiction Medicine. 2024;18(1S):1-56.

• Centers for Disease Control and Prevention. Stimulant Overdose. Overdose Prevention, updated July 17, 2025.

• Centers for Disease Control and Prevention. Polysubstance Use Facts. Stop Overdose, April 2, 2024.

• Substance Abuse and Mental Health Services Administration. Prescription Stimulant Misuse and Prevention Among Youth and Young Adults. Advisory PEP21-06-01-003, November 2021.

• Substance Abuse and Mental Health Services Administration. TAP 32: Clinical Drug Testing in Primary Care. SMA12-4668, 2012.

• Substance Abuse and Mental Health Services Administration. Mandatory Guidelines for Federal Workplace Drug Testing Programs, Oral Fluid. Federal Register, October 25, 2019, effective January 1, 2020.

• U.S. Food and Drug Administration. Drugs of Abuse Home Use Test.

• 988 Suicide and Crisis Lifeline. 988lifeline.org. Call or text 988.